CRSP Profile
CRISPR Therapeutics AG (CRSP) is a biotechnology company that specializes in the development of gene-based medicines using CRISPR gene editing technology. The company's primary focus is on developing treatments for genetic diseases and cancer. CRISPR Therapeutics has several programs in clinical development, including treatments for sickle cell disease and beta thalassemia, two genetic blood disorders, as well as therapies for inherited blindness and certain types of cancer. The company also has collaborations with other pharmaceutical companies to develop gene-based therapies for various diseases. CRISPR Therapeutics is headquartered in Zug, Switzerland, with additional offices in Cambridge, Massachusetts, and London, United Kingdom. As of September 2021, the company had a market capitalization of approximately $14.5 billion.
|
